Business Wire

CALGARY, Alberta--(BUSINESS WIRE)-- E3 LITHIUM LTD. (TSXV: ETL) (FSE: OW3) (OTCQX: EEMMF), “E3 Lithium” or the “Company,” a leader in Canadian lithium, is pleased to announce an update to its agreement with Imperial Oil Limited (“Imperial” or “IOL”).

As part of E3 Lithium and Imperial’s continued collaboration under the agreement first announced in June 2022, the two companies have agreed to increase access to additional freehold lands across the... (continue reading...)

- SWISSto12 has supplied three fully integrated Radio Frequency (RF) Antenna Feed Chains to Northrop Grumman Corporation for one of its GEOStar-3 commercial satellite programs.

- The RF Antenna Feed Chains will be integrated into the GEOStar-3’s payload to meet the stringent requirements of the mission.

- This contract is the first SatComm contract led by SWISSto12’s newly incorporated US Business entity, St12 RF Solutions Inc., which focuses on servicing US... (continue reading...)

• In a commercial world-first, quantum navigation tech developed in the UK was successfully tested in flight
• While GPS jamming is relatively rare and does not directly impact an aircraft’s flight path, quantum systems will provide another layer of security
• The Government has supported the company running the tests, Infleqtion, and their partners from across the country with nearly £8 million as part of its vision to make the UK a leading quantum-enabled... (continue reading...)

NEW YORK--(BUSINESS WIRE)-- Lazard Asset Management (LAM) announced today that it is strengthening its leading Global Thematic platform with the addition of Sarbjit Nahal as a Portfolio Manager / Analyst. The addition of Mr. Nahal bolsters Lazard’s Global Thematic Equity strategies, which seek to benefit from structural change in industries and companies around the world.

“Over the course of his career, Sarbjit has established a leading reputation in the world... (continue reading...)

• Lead Candidate SAP-021 to be Developed on 505(b)(2) FDA Regulatory Pathway Based on Phase 1 Results Demonstrating Bioavailability in Comparison to Epidiolex®
• Patent Protected Production Technology Allows for Scalable Manufacturing of Orally Administered Capsules to Address Large Patient Populations
• Led by Highly Relevant Leadership Team with Deep Understanding of Cannabinoid Pharmaceutical Drug Development

LONDON & MELBOURNE, Australia & NEW... (continue reading...)